Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F2 | P00734 | 2/20 | 0.56 |
| ▸ | F10 | P00742 | 2/20 | 0.56 |
| ▸ | PRSS1 | P07477 | 2/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA3 | P07451 | 1/20 | 0.48 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CA6 | P23280 | 1/20 | 0.48 |
| ▸ | CA5A | P35218 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.48 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4925294 | 1.00 | F2 (0.56) | F2F10PRSS1MEN1KMT2A | |
| SCHEMBL12168556 | 0.87 | CA12 (0.61) | F2F10PRSS1MEN1KMT2A | |
| SCHEMBL6224493 | 0.81 | F2 (0.50) | F2F10PRSS1MEN1KMT2A | |
| Trifluoroacetic Acid SCHEMBL4222286 | 0.80 | CA12 (0.53) | PRSS1CA12CA1CA2CA3 | |
| SCHEMBL12168558 | 0.79 | MEN1 (0.68) | F2F10PRSS1MEN1KMT2A | |
| SCHEMBL6224487 | 0.79 | F2 (0.51) | F2F10PRSS1MEN1KMT2A | |
| SCHEMBL8837255 | 0.78 | ALDH1A1 (0.58) | CA12CA1CA2CA3CA4 | |
| SCHEMBL4927953 | 0.78 | CYP1A2 (0.56) | KMT2ACYP1A2CYP2D6CYP2C9TSHR | |
| SCHEMBL31168314 | 0.78 | CYP1A2 (0.56) | KMT2ACYP1A2CYP2D6CYP2C9TSHR | |
| SCHEMBL15680121 | 0.78 | OPRK1 (0.55) | CYP1A2CYP2D6CYP2C9TSHRCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080070987-A1 | META-XYLYLENEDIAMINE VANADATE SALTS | YRAOLA FONT FRANCESC | 2008-03-20 | — | — | US | claimed |
| WO-2007131996-A1 | META-XYLYLENEDIAMINE VANADATE SALTS | GENMEDICA THERAPEUTICS SL (ES) | 2007-11-22 | — | — | WO | claimed |
| US-20080070987-A1 | META-XYLYLENEDIAMINE VANADATE SALTS | YRAOLA FONT FRANCESC | 2008-03-20 | — | — | US | disclosed |
| WO-2007131996-A1 | META-XYLYLENEDIAMINE VANADATE SALTS | GENMEDICA THERAPEUTICS SL (ES) | 2007-11-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080070987-A1 | META-XYLYLENEDIAMINE VANADATE SALTS | SLC5A1, SLC5A2, SLC2A9 | F2 1899/4885F10 953/4885PRSS1 3109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.